Coronary Insufficiency
2023 Guidelines on the diagnosis and management of chronic coronary syndrome
25 Jan, 2023 | 11:25h | UTC
Retrospective Study | Serial troponin-T and long-term outcomes in suspected acute coronary syndrome
24 Jan, 2023 | 14:09h | UTC
Commentary on Twitter
Serial troponin-T and long-term outcomes in suspected acute coronary syndrome https://t.co/cTm1fJTuKl#AHA22 @ehj_ed @rladeiraslopes pic.twitter.com/0p8cO8zhzi
— European Society of Cardiology Journals (@ESC_Journals) November 7, 2022
Review | Wellens syndrome: an important consideration in patients with chest pain
23 Jan, 2023 | 13:26h | UTCWellens syndrome: An important consideration in patients with chest pain – JAAPA
Commentary: Wellens Syndrome Important to Consider if Chest Pain: Key Points – American College of Cardiology
SR | Comparison of various calcium antagonists on vasospastic angina
18 Jan, 2023 | 14:16h | UTCComparison of various calcium antagonist on vasospastic angina: a systematic review – openheart
The year in cardiovascular medicine 2022: the top 10 papers in acute cardiac care and ischemic heart disease
9 Jan, 2023 | 14:28h | UTC
Commentary on Twitter
The Year in Cardiovascular Medicine 2022 series: the Top 10 papers in Cardiovascular Imaging https://t.co/OVJxxYu71p@escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes #CVD #cvimaging @chiarabd @NAjmoneMarsan pic.twitter.com/sooF0bz3LN
— European Society of Cardiology Journals (@ESC_Journals) January 2, 2023
AHA Scientific Statement | Management of acute coronary syndrome in the older adult population.
13 Dec, 2022 | 14:35h | UTCNews Release: Hearts and bodies change with age, heart disease treatments may need to change, too – American Heart Association
Top Things to Know: Management of ACS in the Older Adult Population – American Heart Association
Commentaries:
The Management of ACS in Older Patients: Is Age Just a Number? – American Heart Association
RCT | Utility of coronary CT angiography for patients with suspected acute coronary syndrome.
9 Dec, 2022 | 13:22h | UTCProspective RandOmised Trial of Emergency Cardiac Computerised Tomography (PROTECCT) – Heart
Commentary on Twitter
PROTECCT Trial @Heart_BMJ shows that immediate coronary CT in ED does not reduce length of stay in patients with suspected #AcuteCoronarySyndrome that cannot be ruled in/out on first #Troponin. @TheBHF @kingscardio @KingsImaging @GSTTresearch https://t.co/ud4rxEpmKl pic.twitter.com/YmKXFWIBZd
— Cardiac Research (@UKheartresearch) October 27, 2022
Under a http://creativecommons.org/licenses/by-nc/4.0/ License
Cohort Study | Race-dependent association of HDL-C levels with incident coronary artery disease.
23 Nov, 2022 | 14:02h | UTCNews Release: Study challenges “good” cholesterol’s role in universally predicting heart disease risk – National Institutes of Health
RCT | Clopidogrel is better than Aspirin for chronic maintenance monotherapy after percutaneous coronary intervention.
17 Nov, 2022 | 12:30h | UTCRelated:
Commentary on Twitter
https://twitter.com/CircAHA/status/1589647384073703426
RCT | Bivalirudin is superior to heparin in patients with ST-segment elevation myocardial infarction undergoing primary PCI.
15 Nov, 2022 | 13:00h | UTCCommentaries:
BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI – TCTMD
RCT | Indobufen vs. aspirin on top of clopidogrel after coronary drug-eluting stent implantation.
11 Nov, 2022 | 14:03h | UTC
Commentary on Twitter
#OriginalResearch simpub #AHA2022 #CIRCAHA22: In this #RCT, indobufen + clopidogrel DAPT compared with aspirin + clopidogrel DAPT significantly reduced the risk of 1-year net clinical outcomes, mainly driven by a reduction in bleeding events without an ….https://t.co/ctk1fwhXt2 pic.twitter.com/vFPS6gvpjN
— Circulation (@CircAHA) November 6, 2022
On the natural history of coronary artery disease: a longitudinal nationwide serial angiography study.
10 Nov, 2022 | 14:03h | UTC
Study Commentary | Radial artery beats both right internal thoracic artery and vein grafting at 15 years.
9 Nov, 2022 | 12:28h | UTC(Not published yet, presented at the American Heart Association Scientific Sessions, November 6, 2022)
RAPCO: Radial Artery Beats Both RITA and Vein Grafting at 15 Years – TCTMD
See also:
Related:
Meta-Analysis: Radial-Artery vs Saphenous-Vein Grafts in CABG
M-A | Comparative efficacy of antiplatelet or anticoagulant therapy in patients with chronic coronary syndromes after PCI.
9 Nov, 2022 | 12:20h | UTC
Follow-up of the ISCHEMIA trial | Similar survival after invasive vs. conservative management of stable coronary disease.
8 Nov, 2022 | 12:32h | UTCSurvival After Invasive or Conservative Management of Stable Coronary Disease – Circulation (free for a limited period)
Original Articles:
ISCHEMIA Trial: Initial Invasive vs. Conservative Strategy for Stable Coronary Disease
ISCHEMIA Trial: Management of Coronary Disease in Patients with Advanced Kidney Disease
See also:
Commentary on Twitter
#OriginalResearch simpub #AHA2022 #CIRCAHA22: From the #ISCHEMIA-EXTEND study – No difference in all-cause mortality between initial invasive vs conservative strategy but ⬇️ risk of CV mortality and ⬆️ risk of non-CV mortality w/ initial invasive strat… https://t.co/XwFS1KO02z pic.twitter.com/SG2z4D3lzY
— Circulation (@CircAHA) November 6, 2022
M-A | Safety and efficacy of interrupting dual antiplatelet therapy one month following percutaneous coronary intervention.
1 Nov, 2022 | 12:14h | UTC
Commentary on Twitter
Interrupting DAPT after 1 month post PCI:
Meta-analysis of 4 RCTs, >25000 pts
Events between 31days and 1yr:
Less bleeding (1.1 vs 1.5%) but no difference in death (1.3 vs 1.6%), MI (1.4 vs 1.2%), ST (0.3 vs 0.2%) or stroke (0.5 vs 0.6%) https://t.co/rdNgCg032B #cardiotwitter pic.twitter.com/yLWREcDzYe— Heeraj Bulluck (@DrHBulluck) October 30, 2022
Under a http://creativecommons.org/licenses/by/4.0/ license
Cohort Study | Pre-eclampsia is associated with increased risk of premature-onset obstructive coronary artery stenosis.
1 Nov, 2022 | 12:02h | UTCSeverity of obstructive coronary artery stenosis after pre-eclampsia – Heart
Related:
AHA Scientific Statement | Adverse Pregnancy Outcomes and Cardiovascular Disease Risk
Cohort Study: Preeclampsia and Cardiovascular Disease
All Hypertensive Disorders of Pregnancy Increase the Risk of Future Cardiovascular Disease
Gestational Hypertension and Future Risk of Cardiovascular Disease
New horizons in Type 2 myocardial infarction: pathogenesis, assessment and management of an emerging geriatric disease.
26 Oct, 2022 | 14:27h | UTC
M-A | Coronary perforation incidence, outcomes and temporal trends.
24 Oct, 2022 | 14:10h | UTC
M-A | The optimal timing for non-culprit PCI in patients with multivessel coronary artery disease.
21 Oct, 2022 | 12:52h | UTC
Cohort Study | 3-year outcomes of patients with spontaneous coronary artery dissection.
19 Oct, 2022 | 14:23h | UTCCanadian Spontaneous Coronary Artery Dissection Cohort Study: 3-Year Outcomes – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Commentary: SCAD Heart Attacks: Outcomes Not as Bad as Previously Feared – Daytonews
Position Statement | Use of biomarkers for the management of heart failure and acute coronary syndrome.
17 Oct, 2022 | 12:34h | UTC
RCT | Allopurinol does not improve outcomes in patients with ischemic heart disease without previous gout.
13 Oct, 2022 | 13:53h | UTCInvited Commentary: Xanthine oxidase inhibition for cardiovascular disease prevention – The Lancet
Commentary on Twitter
Despite favorable effects on surrogate endpoints in smaller trials, in an RCT trial of 5,721 pts with CAD, allopurinol did not significantly improve cardiovascular prognosis compared to placebo https://t.co/ITW4HAwI2K @TheLancet pic.twitter.com/EggHM8flle
— Pradeep Natarajan (@pnatarajanmd) October 7, 2022
Under a Creative Commons Attribution (CC BY 4.0) License
Review | Therapeutic management of anomalous coronary arteries originating from the opposite sinus of Valsalva.
11 Oct, 2022 | 13:32h | UTC
Commentary from the author on Twitter
Hot off the press🔥: happy to share our review in @JAHA_AHA highlighting the management of #ACAOS #AAOCA considering pathophysiology and hemodynamics. @biglermarius @MassimoPadalin3 @MatthiasSiepe @RaberLorenz https://t.co/25hRZlj9wR pic.twitter.com/3F1Oqucq7G
— Christoph Gräni (@chrisgraeni) October 8, 2022
Under a Creative Commons Attribution‐NonCommercial License
M-A of randomized trials | Colchicine and coronary heart disease risks.
3 Oct, 2022 | 14:00h | UTCRelated:
Expert Analysis | Colchicine in acute coronary syndrome: when to commence?
Review: Colchicine and the heart.
M-A: Colchicine administration for percutaneous coronary intervention
M-A: Efficacy and safety of low-dose colchicine in patients with coronary disease
Meta-analysis: Colchicine reduces new cardiovascular events in patients with coronary artery disease
Expert analysis: Efficacy and safety of colchicine in patients with chronic stable coronary disease
#ESCCongress – Randomized trial: Colchicine not beneficial for patients with acute coronary syndrome
Research: Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome